Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 4/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4072853 | 1.00 | LMNA (0.57) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL3634317 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL8026611 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL2592932 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL4949893 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL9304805 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL22471933 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL1697645 | 0.97 | LMNA (0.55) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL11330180 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 | |
| SCHEMBL17822464 | 0.97 | LMNA (0.62) | LMNAOPRM1TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0080992-B1 | 1-PIPERAZINOCARBOXYLATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AB Ferrosan (SE) | 1987-07-15 | — | — | EP | claimed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| CN-112011129-B | Thermoplastic elastomer composition and method for producing same | 住友化学株式会社 | 2023-06-30 | — | — | CN | disclosed |
| WO-2020217628-A1 | METHOD FOR PRODUCING PROPYLENE POLYMER | 住友化学株式会社 | 2020-10-29 | — | — | WO | disclosed |
| US-9199955-B2 | Production of liquid fuels (sylvan-liquid-fuels) from 2-methylfuran | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2015-12-01 | — | — | US | disclosed |
| US-20120316372-A1 | PRODUCTION OF LIQUID FUELS (SYLVAN-LIQUID-FUELS) FROM 2-METHYLFURAN | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2012-12-13 | — | — | US | disclosed |
| EP-2514802-A1 | PRODUCTION OF LIQUID FUELS (SYLVAN LIQUID FUELS) FROM 2-METHYLFURAN | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2012-10-24 | — | — | EP | disclosed |
| WO-1998015516-A1 | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL INTERMEDIATE | EGIS Gyógyszergyár Rt. (HU) | 1998-04-16 | — | — | WO | disclosed |
| US-3998896-A | PRODUCTION OF MONOCHLORO-SUBSTITUTED SATURATED COMPOUNDS | UOP INC. (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | LMNA 149/4885OPRM1 4200/4885TSHR 3901/4885 |
| US-20120316372-A1 | PRODUCTION OF LIQUID FUELS (SYLVAN-LIQUID-FUELS) FROM 2-METHYLFURAN | ADH1A, ADH1C, ADH5 | LMNA 2491/4885OPRM1 1221/4885TSHR 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.